Antengene Corporation Limited ('Antengene', SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical ...

Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.

When children lose their baby teeth, there is an adult set already growing beneath the gums, ready to emerge. But if we lose ...

First preclinical data of novel targeted Radio-DARPin against mesothelin (MSLN), in co-development with Orano Med "Our presentations at AACR highlight the breadth of Molecular Partners' DARPin ...

Patients with spastic paraplegia type 15 develop movement disorders during adolescence that may ultimately require the use of ...

Prime Medicine’s modular editing tech may lower off-target risk, but key data and funding milestones remain ahead. Find out ...

Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals ...

Scientists in the U.K. have developed a new material that may allow them to grow teeth in the lab, which could provide an ...

In a new study, researchers from the University of Copenhagen have successfully created stem cells that are better at ...

Scientists have the technology to grow humans in Petri dishes, but they say there are better uses for it: to combat aging.

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...